These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2597840)

  • 1. Dexamethasone suppression test in dementia and depression. Clinical and biological correlates.
    Shrimankar J; Soni SD; McMurray J
    Br J Psychiatry; 1989 Mar; 154():372-7. PubMed ID: 2597840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients.
    Shrimankar J; Soni SD; Sampath G
    Acta Psychiatr Scand; 1988 Jun; 77(6):712-8. PubMed ID: 3407439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of dexamethasone suppression test in early Alzheimer dementia.
    De Leo D; Schifano F; Magni G
    Eur Arch Psychiatry Neurol Sci; 1988; 238(1):19-21. PubMed ID: 3215214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines.
    Molchan SE; Hill JL; Mellow AM; Lawlor BA; Martinez R; Sunderland T
    Int Psychogeriatr; 1990; 2(2):99-122. PubMed ID: 1713799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of the DST in a psychogeriatric population.
    McKeith IG
    Br J Psychiatry; 1984 Oct; 145():389-93. PubMed ID: 6487912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.
    Greenwald BS; Mathé AA; Mohs RC; Levy MI; Johns CA; Davis KL
    Am J Psychiatry; 1986 Apr; 143(4):442-6. PubMed ID: 3953887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the dexamethasone suppression test with depressed and demented elderly.
    Gierl B; Groves L; Lazarus LW
    J Am Geriatr Soc; 1987 Feb; 35(2):115-20. PubMed ID: 3805553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients.
    Rothschild AJ; Benes F; Hebben N; Woods B; Luciana M; Bakanas E; Samson JA; Schatzberg AF
    Biol Psychiatry; 1989 Oct; 26(6):565-75. PubMed ID: 2790096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia.
    Raskind M; Peskind E; Rivard MF; Veith R; Barnes R
    Am J Psychiatry; 1982 Nov; 139(11):1468-71. PubMed ID: 7137397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the ischemic score in degenerative and vascular dementia and depression in old age.
    Wagner O; Oesterreich K; Hoyer S
    Arch Gerontol Geriatr; 1985 Dec; 4(4):333-45. PubMed ID: 3833087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in demented outpatients with and without depression.
    Carnes M; Smith JC; Kalin NH; Bauwens SF
    Psychiatry Res; 1983 Aug; 9(4):337-44. PubMed ID: 6580662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type.
    Jenike MA; Albert MS
    J Am Geriatr Soc; 1984 Jun; 32(6):441-4. PubMed ID: 6725805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone suppression test in depression with reversible dementia.
    Alexopoulos GS; Young RC; Haycox JA; Shamoian CA; Blass JP
    Psychiatry Res; 1985 Dec; 16(4):277-85. PubMed ID: 4089057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lack of relationship between DST nonsuppression in the dexamethasone suppression test and EEG abnormalities.
    Pitchot W; Hansenne M; Ansseau M
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):193-4. PubMed ID: 1790166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the diagnostic value of the dexamethasone suppression test in endogenous depression.
    Aguilar MT; Lemaire M; Castro P; Libotte M; Reynders J; Herchuelz A
    J Affect Disord; 1984 Feb; 6(1):33-42. PubMed ID: 6231328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in early-onset Alzheimer's disease: clinical and neuroendocrine correlates.
    Krishnan KR; Heyman A; Ritchie JC; Utley CM; Dawson DV; Rogers H
    Biol Psychiatry; 1988 Dec; 24(8):937-40. PubMed ID: 3233234
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities and problems of the detection of dementia syndromes in middle and advanced age using psychological tests].
    Wagner O
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(4):43-53. PubMed ID: 2413538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG and computed tomography in the investigation of patients with senile dementia.
    Soininen H; Partanen JV; Puranen M; Riekkinen PJ
    J Neurol Neurosurg Psychiatry; 1982 Aug; 45(8):711-4. PubMed ID: 7130994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the dexamethasone suppression test have clinical utility in psychiatry?
    Baldessarini RJ; Arana GW
    J Clin Psychiatry; 1985 Feb; 46(2 Pt 2):25-9. PubMed ID: 3968053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in dementia.
    Magni G; Schifano F; De Leo D; Zangaglia O
    Ital J Neurol Sci; 1987 Apr; 8(2):125-8. PubMed ID: 3597052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.